venetoclax
Targeted Therapies
Common brand names
- Venclexta
Approved use in
- Acute Myeloid Leukemia
- B-Cell Prolymphocytic Leukemia
- Chronic Lymphocytic Leukemia
- Follicular Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Myelodysplastic Syndromes
- Peripheral T-Cell Lymphoma
- T-Cell Prolymphocytic Leukemia
Administration method
- Oral
Information about use in Follicular Lymphoma
Information about use in Blood Cancer
Information about use in Multiple Myeloma
Information about use in Acute Myeloid Leukemia
Information about use in B-Cell Prolymphocytic Leukemia
Information about use in Chronic Lymphocytic Leukemia
Information about use in Mantle Cell Lymphoma
Information about use in Peripheral T-Cell Lymphoma
Information about use in T-Cell Prolymphocytic Leukemia
Information about use in Myelodysplastic Syndromes